Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Some treatment plants effectively remove drugs, hormones from wastewater

26.08.2004


Given the number of human pharmaceuticals and hormones that make their way into wastewater, some people are concerned about how well treatment plants that turn sewage into reusable water remove these chemicals.



New research shows that wastewater treatment plants that employ a combination of purifying techniques followed by reverse osmosis - a process by which water is forced through a barrier that only water can pass - do a good job of removing chemicals that may elicit health effects.

Details were presented today (Aug. 25), at the 228th American Chemical Society meeting in Philadelphia as part of a special symposium on pharmaceuticals and personal care products in the environment.


"As the demand for water continues to increase, especially in arid areas, there’s greater pressure placed on an already shrinking water supply," says Joel Pedersen, a University of Wisconsin-Madison environmental chemist, who co-authored a paper detailing this research. "More people are considering the reuse of water."

Wastewater reclamation plants - treatment plants that use additional processes to purify sewage - are already in operation. They produce water to irrigate crops, highway landscaping, golf courses and parks, as well as to be reintroduced into the ground for groundwater recharge, which ultimately could end up in drinking-water supplies.

While this treatment process has the promise to save an evaporating natural resource, Pedersen points out that little is known about just how well water-reclamation plants remove the pharmaceuticals and hormones that typically are found in sewage.

"One concern about water that comes from water-reclamation plants," says the Wisconsin scientist, "is that drugs and hormones in this water aren’t removed during the treatment process."

As Pedersen explains, wastewater typically contains any number of pharmaceuticals and hormones that people have either excreted or flushed away for easy disposal. Many times, these chemical compounds remain biologically active, he says, adding that some of them, especially hormones such as estrogen, appear to significantly alter aquatic organisms.

To investigate how well reclamation plants remove potentially harmful drugs and hormones from wastewater, Pedersen and environmental scientists from the University of California Los Angeles tested the water coming out of three Californian treatment plants, two of which produced recycled water used to recharge groundwater. They looked for detectable levels of 19 contaminants, including ibuprofen, caffeine, testosterone, and drugs that lower cholesterol and inhibit seizures.

Pedersen says that the presence of these drugs and hormones in the reused wastewater would be of particular concern if the concentrations were high enough to elicit health and ecological effects. Much work still needs to be done to determine whether low levels found in wastewater are a cause for concern, he adds.

The team of scientists sampled water from all three plants both before and after the water underwent additional treatment processes. While wastewater that had undergone conventional treatment was filtered to remove larger particles, the reclamation plants used additional techniques to remove smaller particles - such as adding lime before filtration or passing water through a microfilter - and then reverse osmosis, a method by which water is forced through a semipermeable membrane that blocks the passage of other molecules.

The research shows that water-reclamation plants employing reverse osmosis do in fact remove more contaminants.

For example, the conventional treatment plant, which after initial treatment still contained detectable levels of 13 of the different contaminants under study, eliminated only five of them from the discharged water. The two reclamation plants, which had 16 and 14 different contaminants present after initial treatment, eliminated 16 and 12 of the chemical compounds, respectively.

"Conventional wastewater treatment processes don’t eliminate pharmaceuticals and hormones as effectively, resulting in the release of low levels of these compounds into the environment," says Pedersen. "The more advanced processes, on the other hand, do a pretty good job at removing compounds."

Yet, exactly what these differences in contaminant removal may mean for the environment - and even human health - remains uncertain, says Pedersen. "This is a case where the analytical chemistry is ahead of the toxicology," he says. "Right now, the ecological effects of chronic low-level exposure to many of these pharmaceuticals are unknown."

Joel Pedersen | EurekAlert!
Further information:
http://www.wisc.edu

More articles from Life Sciences:

nachricht What happens in the cell nucleus after fertilization
06.12.2016 | Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt

nachricht Researchers uncover protein-based “cancer signature”
05.12.2016 | Universität Basel

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Significantly more productivity in USP lasers

In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.

Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

Simple processing technique could cut cost of organic PV and wearable electronics

06.12.2016 | Materials Sciences

3-D printed kidney phantoms aid nuclear medicine dosing calibration

06.12.2016 | Medical Engineering

Robot on demand: Mobile machining of aircraft components with high precision

06.12.2016 | Power and Electrical Engineering

VideoLinks
B2B-VideoLinks
More VideoLinks >>>